KraneShares MSCI All China Health Care Index ETF
- ETF
- Ticker KURE
- NYSE
Performance, volatility and drawdowns of KraneShares MSCI All China Health Care Index ETF since 02/2018, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $5,753. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −68.4% in 07/2024, measured from the peak in 02/2021. The old peak has not been reached again yet.
Annual returns
Best year 2020 at +69.0%, weakest 2022 at −25.4%. 3 of 7 full years were positive. * partial year.
Similar ETFs
Frequently asked questions
How has KURE performed since 02/2018?
$10,000 grew to $8,304 by 20 Nov 2026, which is −2.1% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is KURE?
Volatility was 28.0% per year, measured on monthly returns. The largest decline from a peak was −68.4%, with the low in 07/2024.
How does KURE compare with a broad equity ETF?
Over the same period Global equities (VT) returned +9.2% per year at 15.9% volatility, KURE returned −2.1% at 28.0%. The correlation of monthly returns was 0.31; 1 would mean they moved in lockstep.
What does KURE hold?
KURE holds 50 positions. The largest are BEONE MEDICINES LTD-H, INNOVENT BIOLOGICS INC and WUXI BIOLOGICS CAYMAN INC; the 10 largest together make up 53.9% of the fund (holdings as of 30 Jun 2026, according to the fund's filing with the SEC).
Which currency are the figures in?
In US dollars, the currency of the US listing.